TW200700398A - Substituted n-sulfonylaminophenylethyl-2-phenoxyacetamide compounds - Google Patents

Substituted n-sulfonylaminophenylethyl-2-phenoxyacetamide compounds

Info

Publication number: TW200700398A
Authority: TW; Taiwan
Prior art keywords: alkyl; alkoxy; hydroxy; halo; halogen atom
Prior art date: 2005-03-10

Application number

TW095108023A

Other languages

English (en)

Inventor

Takeshi Hanazawa

Misato Hirano

Tadashi Inoue

Satoshi Nagayama

Kazunari Nakao

Yuji Shishido

Hirotaka Tanaka

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-03-10

Filing date

2006-03-09

Publication date

2007-01-01

2006-03-09 Application filed by Pfizer filed Critical Pfizer

2007-01-01 Publication of TW200700398A publication Critical patent/TW200700398A/zh

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Physical Education & Sports Medicine (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Diabetes (AREA)
Immunology (AREA)
Child & Adolescent Psychology (AREA)
Vascular Medicine (AREA)
Hematology (AREA)
Obesity (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

TW095108023A 2005-03-10 2006-03-09 Substituted n-sulfonylaminophenylethyl-2-phenoxyacetamide compounds TW200700398A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US66097805P	2005-03-10	2005-03-10

Publications (1)

Publication Number	Publication Date
TW200700398A true TW200700398A (en)	2007-01-01

Family

ID=36297248

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW095108023A TW200700398A (en)	2005-03-10	2006-03-09	Substituted n-sulfonylaminophenylethyl-2-phenoxyacetamide compounds

Country Status (16)

Country	Link
US (1)	US7566739B2 (zh)
EP (1)	EP1858865B1 (zh)
JP (1)	JP4906839B2 (zh)
AR (1)	AR052938A1 (zh)
AT (1)	ATE443056T1 (zh)
CA (1)	CA2600409C (zh)
DE (1)	DE602006009231D1 (zh)
DO (1)	DOP2006000060A (zh)
ES (1)	ES2331153T3 (zh)
GT (1)	GT200600107A (zh)
MX (1)	MX2007011105A (zh)
NL (1)	NL1031335C2 (zh)
PE (1)	PE20061163A1 (zh)
TW (1)	TW200700398A (zh)
UY (1)	UY29412A1 (zh)
WO (1)	WO2006095263A1 (zh)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU714980B2 (en)	1996-07-24	2000-01-13	Warner-Lambert Company Llc	Isobutylgaba and its derivatives for the treatment of pain
BRPI0608714A2 (pt) *	2005-03-19	2010-01-26	Amorepacific Corp	compostos, isÈmeros dos mesmos, ou sais farmaceuticamente aceitáveis dos mesmos como antagonista do receptor vanilóide, e composições farmacêuticas contendo os mesmos
WO2007120012A1 (en) *	2006-04-19	2007-10-25	Amorepacific Corporation	Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
EP2054411B1 (en)	2006-07-27	2014-08-20	Amorepacific Corporation	Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
JP5643112B2 (ja)	2008-01-28	2014-12-17	アモーレパシフィックコーポレイションＡｍｏｒｅｐａｃｉｆｉｃＣｏｒｐｏｒａｔｉｏｎ	バニロイド受容体としての新規化合物、その異性体または薬剤学的に許容し得る塩、及びこれを含有する医薬組成物
US11969501B2 (en)	2008-04-21	2024-04-30	Dompé Farmaceutici S.P.A.	Auris formulations for treating otic diseases and conditions
KR20130097813A (ko)	2008-04-21	2013-09-03	오토노미, 인코포레이티드	귀 질환 및 병태를 치료하기 위한 귀 조제물
KR101621444B1 (ko)	2008-07-02	2016-05-19	(주)아모레퍼시픽	바닐로이드 수용체 길항제로 작용하는 신규 화합물, 이의 이성질체 또는 이의 약제학적으로 허용 가능한 염, 및 이를 포함하는 약학 조성물
WO2010011605A2 (en)	2008-07-21	2010-01-28	Otonomy, Inc.	Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders
US8349852B2 (en)	2009-01-13	2013-01-08	Novartis Ag	Quinazolinone derivatives useful as vanilloid antagonists
JP2013518085A (ja)	2010-02-01	2013-05-20	ノバルティスアーゲー	ＣＲＦ−１受容体アンタゴニストとしてのピラゾロ［５，１ｂ］オキサゾール誘導体
WO2011092293A2 (en)	2010-02-01	2011-08-04	Novartis Ag	Cyclohexyl amide derivatives as crf receptor antagonists
CN102753527B (zh)	2010-02-02	2014-12-24	诺华股份有限公司	用作crf受体拮抗剂的环己基酰胺衍生物
US8975443B2 (en)	2010-07-16	2015-03-10	Abbvie Inc.	Phosphine ligands for catalytic reactions
US9255074B2 (en)	2010-07-16	2016-02-09	Abbvie Inc.	Process for preparing antiviral compounds
UA113498C2 (xx)	2010-07-16	2017-02-10		Фосфінові ліганди для каталітичних реакцій
SG187102A1 (en)	2010-07-16	2013-02-28	Abbvie Inc	Process for preparing antiviral compounds
CN109689027A (zh)	2016-06-29	2019-04-26	奥德纳米有限公司	甘油三酯耳用制剂及其用途
US20200039922A1 (en) *	2016-10-05	2020-02-06	Afecta Pharmaceuticals, Inc.	High mobility group b1 protein inhibitors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4810716A (en)	1986-04-11	1989-03-07	Warner-Lambert Company	Diarylalkanoids having activity as lipoxygenase inhibitors
US5585388A (en)	1995-04-07	1996-12-17	Sibia Neurosciences, Inc.	Substituted pyridines useful as modulators of acetylcholine receptors
CN1390206A (zh)	1999-09-17	2003-01-08	千嬉药品公司	因子Xa的抑制剂
US6632815B2 (en)	1999-09-17	2003-10-14	Millennium Pharmaceuticals, Inc.	Inhibitors of factor Xa
MX226123B (es)	1999-09-17	2005-02-07	Millennium Pharm Inc	Benzamidas e inhibidores del factor xa relacionadas.
AU2001250783A1 (en)	2000-02-29	2001-09-12	Cor Therapeutics, Inc.	Benzamides and related inhibitors of factor xa
EP1311478B1 (en) *	2000-08-21	2006-06-07	Pacific Corporation	Novel (thio)urea compounds and the pharmaceutical compositions containing the same
ATE393141T1 (de) *	2000-08-21	2008-05-15	Pacific Corp	Neue thiourea-derivate und pharmazeutische zusammensetzungen die diese enthalten
CA2458446A1 (en)	2001-10-04	2003-04-17	Novartis Ag	Cyanoacetyl compounds
CA2484233A1 (en)	2002-05-13	2003-11-27	Eli Lilly And Company	Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
KR100556158B1 (ko) *	2002-10-17	2006-03-06	(주) 디지탈바이오텍	신규 엔-하이드록시 티오우레아, 우레아 및 아미드계화합물 및 이를 함유하는 약제학적 조성물
KR100707123B1 (ko) *	2003-07-02	2007-04-16	그뤼넨탈 게엠베하	바닐로이드 수용체의 길항제로서 강력한 진통효과를나타내는 4-(메틸설포닐아미노)페닐 동족체 및 이를함유하는 약학적 조성물
US20050085449A1 (en)	2003-10-15	2005-04-21	Dalton James T.	Haloacetamide and azide substituted compounds and methods of use thereof
CA2541894A1 (en)	2003-10-24	2005-05-06	Kissei Pharmaceutical Co., Ltd.	Amino alcohol derivative, medicinal composition containing the same, and use of these
CN101087771A (zh) *	2004-11-10	2007-12-12	辉瑞大药厂	经取代n－磺酰基氨基苄基－2－苯氧基乙酰胺化合物

2006
- 2006-02-24 MX MX2007011105A patent/MX2007011105A/es active IP Right Grant
- 2006-02-24 EP EP06710536A patent/EP1858865B1/en not_active Not-in-force
- 2006-02-24 CA CA2600409A patent/CA2600409C/en not_active Expired - Fee Related
- 2006-02-24 ES ES06710536T patent/ES2331153T3/es active Active
- 2006-02-24 DE DE602006009231T patent/DE602006009231D1/de active Active
- 2006-02-24 WO PCT/IB2006/000539 patent/WO2006095263A1/en not_active Ceased
- 2006-02-24 AT AT06710536T patent/ATE443056T1/de not_active IP Right Cessation
- 2006-02-24 JP JP2008500290A patent/JP4906839B2/ja not_active Expired - Fee Related
- 2006-03-08 PE PE2006000268A patent/PE20061163A1/es not_active Application Discontinuation
- 2006-03-08 UY UY29412A patent/UY29412A1/es not_active Application Discontinuation
- 2006-03-08 AR ARP060100869A patent/AR052938A1/es unknown
- 2006-03-09 TW TW095108023A patent/TW200700398A/zh unknown
- 2006-03-09 DO DO2006000060A patent/DOP2006000060A/es unknown
- 2006-03-09 NL NL1031335A patent/NL1031335C2/nl not_active IP Right Cessation
- 2006-03-09 GT GT200600107A patent/GT200600107A/es unknown
- 2006-03-10 US US11/372,706 patent/US7566739B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ES2331153T3 (es)	2009-12-22
PE20061163A1 (es)	2006-10-27
NL1031335A1 (nl)	2006-09-12
JP2008532994A (ja)	2008-08-21
GT200600107A (es)	2006-12-26
US7566739B2 (en)	2009-07-28
UY29412A1 (es)	2006-10-31
JP4906839B2 (ja)	2012-03-28
CA2600409C (en)	2011-07-05
WO2006095263A1 (en)	2006-09-14
AR052938A1 (es)	2007-04-11
EP1858865A1 (en)	2007-11-28
DE602006009231D1 (de)	2009-10-29
ATE443056T1 (de)	2009-10-15
US20060205980A1 (en)	2006-09-14
DOP2006000060A (es)	2006-09-30
EP1858865B1 (en)	2009-09-16
CA2600409A1 (en)	2006-09-14
MX2007011105A (es)	2007-10-08
WO2006095263A8 (en)	2007-11-08
NL1031335C2 (nl)	2007-01-23

Publication	Publication Date	Title
TW200700398A (en)	2007-01-01	Substituted n-sulfonylaminophenylethyl-2-phenoxyacetamide compounds
AP1822A (en)	2008-01-30	Substituted pyridinones as modulators of P38 MAP kinase.
MXPA05010621A (es)	2005-11-23	Pirimidinonas sustituidas.
TW200517109A (en)	2005-06-01	Substituted pyridinones
MX2009004096A (es)	2009-06-16	Metabolitos de talarozol.
WO2006011050A3 (en)	2006-10-05	Pyridine derivatives
WO2009016462A3 (en)	2009-03-26	Substituted bicyclolactam compounds
MXPA05012678A (es)	2006-02-22	Forma cristalina del agonista del receptor adrenergico beta2.
TW200716528A (en)	2007-05-01	Cyclopropanecarboxamide derivatives
WO2008012635A3 (en)	2008-05-08	Amine derivatives useful as anticancer agents
UA85576C2 (ru)	2009-02-10	Тетразольные соединения и их применение в качестве метаботропических антагонистов рецепторов глутамата
EP2966065A3 (en)	2016-03-02	Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors
WO2008076243A3 (en)	2009-03-26	Acyl bipiperidinyl compounds, compositions containing such compounds and methods of treatment
WO2008059370A3 (en)	2008-07-24	Substituted bicyclocarboxyamide compounds
WO2008050199A8 (en)	2009-04-16	Substituted phenylmethyl bicyclocarboxyamide compounds
WO2005095401A8 (en)	2005-11-17	Alpha-trifluoromethyl alcohols or amines as glucocorticoid mimetics
MY140235A (en)	2009-12-31	New benzimidazole derivatives
TW200806311A (en)	2008-02-01	Neuropeptide-2 receptor-agonists
TW200740787A (en)	2007-11-01	(6-Fluoro-benzo[1,3]dioxolyl)-morpholin-4-yl-methanones
MXPA06009475A (es)	2007-05-15	Derivados de quinazolina y usos terapeuticos de los mismos.
MXPA05013151A (es)	2006-03-17	3-fluoro-piperidinas como antagonistas de n-metil-d-aspartato/nr2b.
TW200621694A (en)	2006-07-01	Substituted n-sulfonylaminobenzyl-2-phenoxyacetamide compounds
WO2006057922A3 (en)	2006-08-31	Niacin receptor agonists, compositions containing such compounds and methods of treatment
WO2007125398A3 (en)	2008-03-06	: sulfonamide compounds as antagonists of the n-type calcium channel
PL1725536T3 (pl)	2009-04-30	Pochodne imidazoliny mające czynność CB1-antagonistyczną